Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL)

Blood

Volumn 106, Issue 12, 2005, Pages 3926-3931

  Zambello, Renato ^b   Berno, Tamara ^b   Cannas, Giovanna ^b   Baesso, Ilenia ^b   Binotto, Gianni ^b   Bonoldi, Emanuela ^b   Bevilacqua, Pierantonio ^b   Miorin, Marta ^b   Facco, Monica ^b   Trentin, Livio ^b   Agostini, Carlo ^b   Semenzato, Gianpietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW BIOPSY; CD34 SELECTION; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CELL TYPE; CELLULAR DISTRIBUTION; CIRCULATION; CONTROLLED STUDY; DENDRITIC CELL; FUNCTIONAL ASSESSMENT; GENETIC ORGANIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; PHENOTYPE; PRIORITY JOURNAL; TOPOGRAPHY;

EID: 28444480197     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-05-1972     Document Type: Article

References (29)

1. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999;13:230-240.
2. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TPJ. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;86:256-260.
3. Zambello R, Semenzato G. Large granular lymphocytosis. Haematologica. 1998;83:936-942.
4. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1-14.
5. Zambello R, Trentin L, Ciccone E, et al. Phenotypic diversity of natural killer populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood. 1993;81:2381-2385.
6. Zambello R, Semenzato G. Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes. Semin Hematol. 2003;40:201-212.
7. Zambello R, Facco M, Trentin L, et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood. 1997;89:201-211.
8. Moretta L, Bottino C, Ferlazzo G, et al. Surface receptors and functional interactions of human natural killer cells: from bench to the clinic. Cell Mol Life Sci. 2003;60:2139-2146.
9. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195:343-351.
10. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol. 2005;5:112-124.
11. Oshimi K, Shinkai Y, Okumura K, Oshimi Y, Mizoguchi H. Perforin gene expression in granular lymphocyte proliferative disorders. Blood. 1990;75:704-708.
12. Epling-Burnette PK, Bai F, Wei S, et al. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene. 2004;23:9220-9229.
13. - (natural killer) lymphoproliferative disease of granular lymphocytes. Blood. 1997;90:1977-1981.
14. Hart DN, Baker BW, Inglis MJ, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood. 1992;79:2116-2123.
15. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol. 1997;54:276-281.
16. Zambello R, Loughran TP Jr, Trentin L, et al. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. Leukemia. 1995;9:1207-1211.
17. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 1989;84:51-55.
18. + immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody. Immunology. 2003;109:476-486.
19. + T cells. J Exp Med. 2001;193:219-231.
20. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037-6046.
21. Anthony DD, Yonkers NL, Post AB, et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol. 2004;172:4907-4916.
22. Arpinati M, Chirumbolo G, Urbini B, Perrone G, Rondelli D, Anasetti C. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl Immunol. 2003;11:345-356.
23. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol. 2004;25:47-52.
24. Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin Hematol. 2003;40:185-195.
25. Morice WG, Kurtin PJ, Tefferi A, Hanson CA. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood. 2002;99:268-274.
26. + granular lymphocytes. Cancer Res. 1995;55:6140-6145.
27. + leukemic large granular lymphocytes utilize diverse T-cell receptor V beta genes. Blood. 1995;85:146-150.
28. Epling-Burnette PK, Painter JS, Chaurasia P, et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood. 2004;103:3431-3439.
29. + lymphoproliferative disease of granular lymphocytes. Leukemia. 2004;18:771-776.